HuGE Literature Finder
Records
1
-
3
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. International journal of biological sciences 2016 12 (12): 1523-1532. Chou Wen-Chi, Lin Po-Han, Yeh Yi-Chen, Shyr Yi-Ming, Fang Wen-Liang, Wang Shin-E, Liu Chun-Yu, Chang Peter Mu-Hsin, Chen Ming-Han, Hung Yi-Ping, Li Chung-Pin, Chao Yee, Chen Ming-Hua |
The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy. Cancer research 2012 Nov 72 (22): 5683-91. Serra Stefano, Zheng Lei, Hassan Manal, Phan Alexandria T, Woodhouse Linda J, Yao James C, Ezzat Shereen, Asa Sylvia |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: